FMP
Bone Therapeutics SA
BOTHE.BR
EURONEXT
Inactive Equity
Bone Therapeutics SA, a biotechnology company, engages in the development of cell therapy products for orthopedics and bone diseases. Its products include ALLOB, an allogeneic cell therapy product, which is in Phase I/IIa clinical trial for the treatment of delayed-union fractures and lumbar spinal fusion; and JTA-004, an intra-articular injectable that is in phase III clinical trial to treat osteoarthritic pain in the knee. Bone Therapeutics SA was incorporated in 2006 and is based in Mont-Saint-Guibert, Belgium.
0.29 EUR
0 (0%)
About
ceo
Dr. Miguel Forte M.D., Ph.D.
sector
Healthcare
industry
Biotechnology
website
https://www.bonetherapeutics.com
exchange
EURONEXT
Description
Bone Therapeutics SA, a biotechnology company, engages in the development of cell therapy products for orthopedics and bone diseases. Its products include ALLOB, an allogeneic cell therapy product, which is in Phase I/IIa clinical trial for the treatment of delayed-union fractures and lumbar spinal fusion; and JTA-004, an intra-articular injectable that is in phase III clinical trial to treat osteoarthritic pain in the knee. Bone Therapeutics SA was incorporated in 2006 and is based in Mont-Saint-Guibert, Belgium.
CIK
N/A
ISIN
BE0974280126
CUSIP
N/A
Address
Rue Granbonpré 11 - Bâtiment H
Phone
32 49 309 73 66
Country
BE
Employee
20
IPO Date
Feb 6, 2015
Key Executives
